Evaluation of Hematuria in the Elderly

Initial Assessment

• The American Academy of Family Physicians recommends determining if hematuria is gross or microscopic, with gross hematuria carrying a higher risk of malignancy (30-40%) compared to microscopic hematuria (2.6-4%) 1
• The American College of Radiology and the American Academy of Family Physicians suggest excluding benign causes, including infection, vigorous exercise, trauma, and medications, and obtaining a clean-catch urine specimen, considering catheterization if necessary 2, 1

Laboratory Evaluation

• A complete urinalysis with microscopic examination should assess the number of red blood cells per high-power field, presence of dysmorphic red blood cells or red cell casts, and presence of white blood cells or bacteria, according to the American Academy of Family Physicians 1, 3
• Urine culture is recommended to rule out urinary tract infection, and serum creatinine should be measured to assess renal function, as suggested by the American Academy of Family Physicians 1, 3
• The American Academy of Family Physicians recommends urine cytology in all patients with hematuria at age 80 due to the high risk for transitional cell carcinoma 1

Diagnostic Algorithm

• The American College of Radiology suggests that a glomerular source is likely if there is significant proteinuria, dysmorphic RBCs, red cell casts, or elevated serum creatinine 2, 3
• A non-glomerular (urologic) source is likely if there are normal-shaped RBCs, minimal or no proteinuria, and normal serum creatinine, according to the American Academy of Family Physicians and the American College of Radiology 2, 1, 3

Imaging Recommendations

• The American College of Radiology recommends CT urography as the preferred imaging modality for comprehensive evaluation of the upper urinary tract in an 80-year-old with hematuria, with MR urography as an alternative if CT is contraindicated 2
• Renal ultrasound with retrograde pyelography can be considered if CT and MR are not feasible, as suggested by the American Academy of Family Physicians 1

Specialist Referral

• The American College of Radiology and the American Academy of Family Physicians indicate that urologic referral is necessary for all patients with gross hematuria, patients with microscopic hematuria at age 80, and those with risk factors, including smoking history or occupational exposures 2, 1, 4
• Nephrology referral is recommended if there is evidence of glomerular disease, such as proteinuria, red cell casts, or predominantly dysmorphic RBCs, according to the American Academy of Family Physicians 1, 3

Follow-up Recommendations

• For patients with negative initial evaluation, the American Academy of Family Physicians suggests repeating urinalysis at 6, 12, 24, and 36 months, monitoring blood pressure, and considering nephrology referral if hematuria persists with development of hypertension, proteinuria, or evidence of glomerular bleeding 1, 4

Urgent Urologic Referral for Gross Hematuria in Elderly Patients

Initial Assessment

• The combination of flank pain and hematuria in an elderly patient raises concern for several serious conditions, including urinary tract malignancy (bladder or upper tract), with a high probability in this age group 5, 6

Diagnostic Approach

• The urinalysis shows large blood with negative leukocytes and nitrites, suggesting a non-infectious etiology, according to the European Urology guidelines 7
• CT urography (CT abdomen/pelvis with IV contrast) is the preferred initial imaging modality for comprehensive evaluation of the urinary tract in an elderly patient with hematuria, as recommended by the Journal of the American College of Radiology 8, 9

Specialist Referral

• Urgent urologic referral is mandatory for all patients with gross hematuria, even if self-limited, as stated by the American College of Physicians, published in Annals of Internal Medicine 5, 6, 10
• The urologist will likely perform cystoscopy to exclude bladder cancer, as suggested by the American Family Physician guidelines 9

Important Considerations

• Do not delay evaluation even if hematuria resolves spontaneously, as advised by the American College of Physicians, published in Annals of Internal Medicine 6
• The absence of infection markers increases concern for malignancy or other serious pathology, according to the European Urology guidelines 7

Common Pitfalls to Avoid

• Do not assume hematuria is due to antiplatelet or anticoagulant medications if the patient is taking them, as stated by the American College of Physicians, published in Annals of Internal Medicine 10
• Do not delay urologic referral while waiting for other test results in a patient with gross hematuria, as recommended by the American College of Physicians, published in Annals of Internal Medicine 5, 6

Evaluation and Management of Gross Hematuria

Initial Assessment

• All patients with gross hematuria require urgent urologic referral for cystoscopy and imaging due to the high risk of underlying malignancy (>10%), even if the bleeding is self-limited 11
• Painless gross hematuria has a stronger association with cancer than hematuria accompanied by flank pain, which may suggest urinary stone disease 11
• Do not attribute hematuria solely to antiplatelet or anticoagulant therapy without further investigation 11

Diagnostic Approach

• The American College of Physicians does not recommend urine cytology or other urine-based molecular markers for bladder cancer detection in the initial evaluation 11

Specialist Referral

• Urgent urologic referral is mandatory for all patients with gross hematuria, even if self-limited 11
• Urinary tract malignancy (bladder, kidney, ureter) is a potential cause of gross hematuria 11

Follow-up Recommendations

• For patients with negative initial evaluation, repeat urinalysis at 6, 12, 24, and 36 months 12
• Monitor blood pressure and consider nephrology referral if hematuria persists with development of hypertension, proteinuria, or evidence of glomerular bleeding 12
• Immediate urologic reevaluation is necessary if any of the following occur: recurrent gross hematuria, abnormal urinary cytology, or irritative voiding symptoms in the absence of infection 12

Imaging Recommendations for Gross Hematuria in End‑Stage Renal Disease (ESRD) Patients

Preferred Imaging Modality and Limitations

Alternative Imaging Strategies When Renal Function Is Severely Reduced

Common Urologic Cause of Gross Hematuria in ESRD

High‑Risk Features and Mandatory Diagnostic Steps for Gross Hematuria with Acute Urinary Retention

Risk Assessment

• The transition from painless to painful urination accompanied by increasing frequency and urgency is a high‑risk indicator for urothelial malignancy; irritative voiding symptoms without documented infection are strongly linked to bladder cancer or carcinoma in situ. 15

• Painless gross hematuria is the classic presentation of bladder cancer, and painless bleeding is more suggestive of malignancy than painful bleeding, which more often points to stones or infection. 15

• The emergence of dysuria, frequency, and urgency in a patient with gross hematuria signals possible tumor growth causing irritation, carcinoma in situ (which frequently presents with irritative symptoms), or secondary infection/inflammation. 15

• While prostate cancer with bladder invasion can occur in older individuals, it is less common than primary bladder cancer as the cause of gross hematuria with retention. 15

Diagnostic Evaluation

• Flexible cystoscopy is mandatory and cannot be postponed; bladder cancer accounts for 30–40 % of gross hematuria cases, and direct visualization is required because imaging alone cannot exclude bladder pathology. 15

• Cystoscopy should be performed after clot evacuation and resolution of acute bleeding to ensure adequate visualization of the bladder mucosa, urethra, and ureteral orifices. 15

• If cystoscopy identifies a bladder tumor, immediate transurethral resection of the bladder tumor (TURBT) is recommended for definitive diagnosis and staging, with complete visual resection performed whenever technically feasible. 15